TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ERAS

Erasca Inc

Healthcare · Biotechnology

15.00$ +1.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Erasca Inc (ERAS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 396 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ERAS
Line item 2019 2020 2021 2022 2023 2024 2025
56 125 501 515 395 503 396
51 120 420 444 321 309 286
30 65 360 284 93 68 74
50 119 459 436 312 298 276
0.1 2.3 2.5
4.3 4.1 16 25
69 239 45 103 79 79 71
2.8 14 26 49 26 31 29
0.7 0.9 0.6 2.6 4.0 9.2 5.1
1.4 0.9 4.7 23 2.0 0.5 1.0
-14 -114 457 412 317 423 325
-14 -115 -238 -481 -606 -768 -892
95 19 95 98 120 234 284

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?